Record #35644

Dual targeting of RANKL and PD-1 with a bispecific antibody improves anti-tumor immunity

Citation lifecycle

How this paper is being cited

Pre-retraction
17
Same day
0
Post-retraction
9
% post-retraction
34.6%
~7.1 citations/yr before retraction · ~2.0 citations/yr after
citing papers

Who is still citing this work

Loading…